|
Rivera-Caravaca JM, Lip GYH, Roldan V, Marin F. Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system. Front Cardiovasc Med. 2022 Oct 17;9:1042728. doi: 10.3389/fcvm.2022.1042728. eCollection 2022. No abstract available. PubMed PMID: 36324744; PubMed Central PMCID: PMC9619039.
AÑO: 2022; IF: 3.6
|
36324744
|
Gavín O., Roldán V., Llamas-Sillero P., Santamaría A., Arumí D., Cabo S.F.d. Characteristics and management of patients with stroke and major hemorrhagic episodes with atrial fibrillation under vitamin K antagonist therapy. EVENTHO study. Medicina Clinica. 28 October 2022. 159:366-371. 10.1016/j.medcli.2021.12.004
AÑO: 2022; IF: 3.9
|
|
Ding WY, Rivera-Caravaca JM, Shantsila A, Marin F, Gupta D, Roldan V, Lip GYH. Outcomes in VKA-treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs 'real-world'. Int J Clin Pract. 2021 Apr;75(4):e13888. doi: 10.1111/ijcp.13888. Epub 2020 Dec 15. PubMed PMID: 33283377.
AÑO: 2021; IF: 3.149
|
|
Sanchez-Fuentes A, Rivera-Caravaca JM, Lopez-Galvez R, Marin F, Roldan V. Non-vitamin K Antagonist Oral Anticoagulants and Drug-Food Interactions: Implications for Clinical Practice and Potential Role of Probiotics and Prebiotics. Front Cardiovasc Med. 2022 Jan 17;8:787235. doi: 10.3389/fcvm.2021.787235. eCollection 2021. PubMed PMID: 35111826; PubMed Central PMCID: PMC8801490.
AÑO: 2021; IF: 5.846
|
|
Steffel J., Collins R., Antz M., Cornu P., Desteghe L., Haeusler K.G., Oldgren J., Reinecke H., Roldan-Schilling V., Rowell N., Sinnaeve P., Vanassche T., Potpara T., Camm A.J., Heidbüchel H., Lip G.Y.H., Deneke T., Dagres N., Boriani G., Chao T.F., Choi E.K., Hills M.T., Santos I.D.S., Lane D.A., Atar D., Joung B., Cole O.M., Field M. 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. Europace. 1 October 2021. 23:1612-1676. 10.1093/europace/euab065
AÑO: 2021; IF: 5.486
|